Researchers analyzed a six-month antibiotic stewardship program in four geriatric wards at a hospital in Sweden and compared its results to those from a temporally matched control period the previous year when physicians were prescribing antibiotics solely based on clinical guidelines.
Most patient outcome measures showed no significant differences, such as mortality, 28-day readmission, adverse events or length of stay. However, readmission rates due to infection were significantly lower in the stewardship program group than the control group, at 4 percent and 7.5 percent, respectively.
Furthermore, patients in the stewardship group experienced a 27 percent reduction in overall antibiotic use.
“This was a noninferiority study, so we were able to show that we achieved a reduction in antibiotics without compromising patient safety,” said Fredrik Resman, MD, lead investigator of the study, in the Medscape report. “It’s hard to show benefit, but you at least need to show noninferiority because you have to show that patients are not getting sicker or dying as a result of fewer antibiotics.”
More articles on antibiotic stewardship:
11M+ unnecessary antibiotics prescribed to children each year
IDSA launches U.S. Stakeholder Forum on Antimicrobial Resistance
Study: Concern over clinical impact of antibiotic resistance found to be lacking in residential aged care facilities
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
